These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28426485)

  • 1. ALK Expression is a Rare Finding in Mycosis Fungoides.
    Covington M; Cassarino D; Abdulla F
    Am J Dermatopathol; 2017 May; 39(5):342-343. PubMed ID: 28426485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
    Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
    Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
    Geller S; Canavan TN; Pulitzer M; Moskowitz AJ; Myskowski PL
    Int J Dermatol; 2018 May; 57(5):515-520. PubMed ID: 29057463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
    Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
    Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression.
    Wang RC; Sakata S; Chen BJ; Chang ST; Hsieh PP; Yang CS; Baba S; Takeuchi K; Chuang SS
    Pathology; 2018 Dec; 50(7):718-724. PubMed ID: 30348505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of ALK in mycosis fungoides, stage IA.
    Abdulla FR; Sarpa H; Cassarino D
    J Cutan Pathol; 2013 Mar; 40(3):348-50. PubMed ID: 23205942
    [No Abstract]   [Full Text] [Related]  

  • 10. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
    Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
    J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
    Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
    Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The different faces of mycosis fungoides: results of a single-center study.
    Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
    Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
    Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
    J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium.
    Kadin ME; Hughey LC; Wood GS
    J Am Acad Dermatol; 2014 Feb; 70(2):374-6. PubMed ID: 24438952
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma.
    Cerroni L; Rieger E; Hödl S; Kerl H
    Am J Surg Pathol; 1992 Jun; 16(6):543-52. PubMed ID: 1599034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
    Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
    Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
    Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
    J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.